Macter expands Cobolmin range with sublingual option

MG News | December 22, 2025 at 03:55 PM GMT+05:00

0:00

December 22, 2025 (MLN): Macter International Limited (PSX: MACTER) introduced Cobolmin SL, a sublingual formulation of Mecobalamin.

The company stated that Cobolmin SL offers rapid absorption and enhanced convenience for patients through sublingual administration, the company’s filing on PSX revealed today.

The product expands the existing Cobolmin range, which includes tablets and injections, and underscores Macter International’s focus on innovation in healthcare.

At the time of writing, MACTER shares were trading at Rs 337.59, up 2.51 points, or 0.75%.

Copyright Mettis Link News

Related News

PTCL dismisses e& exit speculation

PSX Closing Bell: Bears Win

Lotte Chemical switches on smart energy system

Name	Price/Vol	%Chg/NChg
KSE100	162,994.17 366.14M	-1.71% -2829.70
ALLSHR	97,525.91 833.18M	-1.65% -1634.99
KSE30	49,090.22 171.05M	-2.02% -1011.73
KMI30	234,097.76 141.71M	-1.92% -4583.61
KMIALLSHR	63,284.58 381.76M	-1.79% -1151.00
BKTi	45,458.10 90.77M	-1.53% -707.82
OGTi	33,162.89 14.24M	-2.82% -962.44

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	76,795.00	77,030.00 75,655.00	1020.00 1.35%
BRENT CRUDE	110.55	114.70 107.07	0.11 0.10%
RICHARDS BAY COAL MONTHLY	113.00	113.00 113.00	-1.30 -1.14%
ROTTERDAM COAL MONTHLY	109.25	112.00 108.20	-1.20 -1.09%
USD RBD PALM OLEIN	1,191.50	1,191.50 1,191.50	0.00 0.00%
CRUDE OIL - WTI	104.79	110.93 103.34	-2.09 -1.96%
SUGAR #11 WORLD	14.61	14.85 14.49	-0.16 -1.08%